0001209191-23-030794.txt : 20230518
0001209191-23-030794.hdr.sgml : 20230518
20230518183037
ACCESSION NUMBER: 0001209191-23-030794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACARTNEY LAWSON
CENTRAL INDEX KEY: 0001606831
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 23937455
MAIL ADDRESS:
STREET 1: C/O AMBRX, INC.
STREET 2: 10975 N. TORREY PINES RD.
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-16
0
0001607678
Viking Therapeutics, Inc.
VKTX
0001606831
MACARTNEY LAWSON
C/O VIKING THERAPEUTICS, INC.
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock, par value $0.00001 per share
2023-05-16
4
M
0
16000
1.19
A
63965
D
Common Stock, par value $0.00001 per share
2023-05-16
4
S
0
16000
24.00
D
47965
D
Stock Option (Right to Buy)
1.19
2023-05-16
4
M
0
16000
0.00
D
2018-01-03
2027-01-03
Common Stock
16000
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
/s/ Michael Morneau as Attorney-in-Fact
2023-05-18